Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
August 24, 2021 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting...
Global Respiratory Care Medical Devices Market Report 2021-2025: Increasing Demand for Enhanced Portable Devices & Focus of Market Players to Expand Geographic Presence
April 28, 2021 07:33 ET
|
Research and Markets
Dublin, April 28, 2021 (GLOBE NEWSWIRE) -- The "Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's...
COPD and Asthma Devices Market is anticipated to hit $51.62 billion by 2027, At CAGR 4.3%
November 04, 2020 10:00 ET
|
Allied Market Research
Portland, OR, Nov. 04, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research the global COPD and asthma devices market size was estimated at $36.45 billion in 2019,...
Digital Therapeutics Market to Reach $9.64 Bn, Globally, by 2026: Allied Market Research
February 25, 2020 09:34 ET
|
Allied Market Research
Portland, OR, Feb. 25, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global digital therapeutics industry generated $2.24 billion in 2018, and is...
Monaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory Care
November 12, 2019 08:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth...
Significant reductions in costly pulmonary complications with use of drug-free device
June 20, 2018 07:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., June 20, 2018 (GLOBE NEWSWIRE) -- Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in Pulmonary...
New published evidence reinforces the importance of device choice in asthma control
January 31, 2018 08:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Jan. 31, 2018 (GLOBE NEWSWIRE) -- A recent article in Pulmonary Pharmacology and Physiology1 provides in vitro evidence that the AEROCHAMBER PLUS® FLOW-VU® valved holding chamber...
The Aerobika(R) Device, Marketed by Monaghan Medical in the United States, Benefits COPD Patients and Wins Gold at MDEA Awards
July 16, 2014 14:38 ET
|
Monaghan Medical Corporation
PLATTSBURGH, NY--(Marketwired - Jul 16, 2014) - The Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Therapy System marketed by Monaghan Medical Corporation has earned Gold at the...
Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion
June 10, 2013 02:10 ET
|
Pearl Therapeutics
Redwood City, CA, June 10, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics
Inc. today announced that it has entered into a definitive
merger agreement under which the Company will be acquired...